These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26062862)

  • 1. Effects of parathyroid hormone dosage and schedule on bone regeneration.
    Tsunori K
    J Oral Sci; 2015 Jun; 57(2):131-6. PubMed ID: 26062862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of Bone Augmentation in Osteoporotic Conditions by the Intermittent Parathyroid Hormone: An Animal Study in the Calvarium of Ovariectomized Rat.
    Kubota T; Hasuike A; Naito M; Tsunori K; Min S; Sato S
    Int J Oral Maxillofac Implants; 2018; 33(5):1003-1010. PubMed ID: 30231085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent administration of parathyroid hormone improves the repairing process of rat calvaria defects: A histomorphometric and radiodensitometric study.
    Silva ED; Vasconcelos DF; Marques MR; Silva MA; Manzi FR; Barros SP
    Med Oral Patol Oral Cir Bucal; 2015 Jul; 20(4):e489-93. PubMed ID: 26034928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intermittent administration of parathyroid hormone on bone augmentation in rat calvarium.
    Tsunori K; Sato S; Hasuike A; Manaka S; Shino H; Sato N; Kubota T; Arai Y; Ito K; Miyazaki M
    Implant Dent; 2015 Apr; 24(2):142-8. PubMed ID: 25706267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The local administration of parathyroid hormone encourages the healing of bone defects in the rat calvaria: Micro-computed tomography, histological and histomorphometric evaluation.
    Auersvald CM; Santos FR; Nakano MM; Leoni GB; de Sousa Neto MD; Scariot R; Giovanini AF; Deliberador TM
    Arch Oral Biol; 2017 Jul; 79():14-19. PubMed ID: 28282513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical and intermittent application of parathyroid hormone recovers alveolar bone loss in rat experimental periodontitis.
    Tokunaga K; Seto H; Ohba H; Mihara C; Hama H; Horibe M; Yoneda S; Nagata T
    J Periodontal Res; 2011 Dec; 46(6):655-62. PubMed ID: 21722135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of systemic parathyroid hormone (1-34) and a beta-tricalcium phosphate biomaterial on local bone formation in a critical-size rat calvarial defect model.
    Yun JI; Wikesjö UM; Borke JL; Bisch FC; Lewis JE; Herold RW; Swiec GD; Wood JC; McPherson JC
    J Clin Periodontol; 2010 May; 37(5):419-26. PubMed ID: 20236187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone gene-activated matrix with DFDBA/collagen composite matrix enhances bone regeneration in rat calvarial bone defects.
    Lee PH; Yew TL; Lai YL; Lee SY; Chen HL
    J Chin Med Assoc; 2018 Aug; 81(8):699-707. PubMed ID: 29551486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal in vivo analysis of the region-specific efficacy of parathyroid hormone in a rat cortical defect model.
    Komatsu DE; Brune KA; Liu H; Schmidt AL; Han B; Zeng QQ; Yang X; Nunes JS; Lu Y; Geiser AG; Ma YL; Wolos JA; Westmore MS; Sato M
    Endocrinology; 2009 Apr; 150(4):1570-9. PubMed ID: 19022894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional microstructural properties of regenerated mineralizing tissue after PTH (1-34) treatment in a rabbit tibial lengthening model.
    Aleksyniene R; Thomsen JS; Eckardt H; Bundgaard KG; Lind M; Hvid I
    J Musculoskelet Neuronal Interact; 2009; 9(4):268-77. PubMed ID: 19949285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential treatment with intermittent low-dose human parathyroid hormone (1-34) and bisphosphonate enhances large-size skeletal reconstruction by vascularized bone transplantation.
    Hashimoto T; Shigetomi M; Ohno T; Matsunaga T; Muramatsu K; Tanaka H; Sugiyama T; Taguchi T
    Calcif Tissue Int; 2007 Sep; 81(3):232-9. PubMed ID: 17674071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic administration of mesenchymal stem cells combined with parathyroid hormone therapy synergistically regenerates multiple rib fractures.
    Cohn Yakubovich D; Sheyn D; Bez M; Schary Y; Yalon E; Sirhan A; Amira M; Yaya A; De Mel S; Da X; Ben-David S; Tawackoli W; Ley EJ; Gazit D; Gazit Z; Pelled G
    Stem Cell Res Ther; 2017 Mar; 8(1):51. PubMed ID: 28279202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent administration of parathyroid hormone (1-37) improves growth and bone mineral density in uremic rats.
    Schmitt CP; Hessing S; Oh J; Weber L; Ochlich P; Mehls O
    Kidney Int; 2000 Apr; 57(4):1484-92. PubMed ID: 10760084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intermittent administration of human parathyroid hormone on bone mineral density and arthritis in rats with collagen-induced arthritis.
    Fukata S; Hagino H; Okano T; Yamane I; Kameyama Y; Teshima R
    Arthritis Rheum; 2004 Dec; 50(12):4060-9. PubMed ID: 15593226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized rats.
    Washimi Y; Ito M; Morishima Y; Taguma K; Ojima Y; Uzawa T; Hori M
    Bone; 2007 Nov; 41(5):786-93. PubMed ID: 17707708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
    Shen V; Birchman R; Wu DD; Lindsay R
    J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiol-ene Hydrogels for Local Delivery of PTH for Bone Regeneration in Critical Size defects.
    Wojda SJ; Marozas IA; Anseth KS; Yaszemski MJ; Donahue SW
    J Orthop Res; 2020 Mar; 38(3):536-544. PubMed ID: 31709588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accretion of bone mass and strength with parathyroid hormone prior to the onset of estrogen deficiency can provide temporary beneficial effects in skeletally mature rats.
    Shen V; Birchman R; Liang XG; Wu DD; Dempster DW; Lindsay R
    J Bone Miner Res; 1998 May; 13(5):883-90. PubMed ID: 9610753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of recombinant human bone morphogenetic protein-4 with carriers in rat calvarial defects.
    Ahn SH; Kim CS; Suk HJ; Lee YJ; Choi SH; Chai JK; Kim CK; Han SB; Cho KS
    J Periodontol; 2003 Jun; 74(6):787-97. PubMed ID: 12886988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent parathyroid hormone treatment enhances guided bone regeneration in rat calvarial bone defects.
    Andreassen TT; Cacciafesta V
    J Craniofac Surg; 2004 May; 15(3):424-7; discussion 428-9. PubMed ID: 15111801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.